KPV Guide & Dosage Chart

What is KPV?

KPV stands for Lysine-Proline-Valine — a tiny protein fragment made of just three amino acids. It is the C-terminal (tail-end) piece of a larger hormone called alpha-melanocyte-stimulating hormone (α-MSH), which your body makes naturally.^[1] Because KPV is so small, researchers classify it as a tripeptide. It has attracted scientific interest mainly for its anti-inflammatory properties — meaning it may help reduce the biological signals that drive inflammation. It is a research compound and is not approved for human medical use.

How KPV Works

Think of inflammation like a fire alarm that keeps blaring long after the smoke is gone. KPV is being studied as a way to help turn down that alarm at the molecular level.

When cells face a threat — such as airborne pollution particles — they activate two key internal signalling pathways called MAPK and NF-κB. These pathways are like command centres that tell the cell to release inflammatory chemicals. Research in human skin cells (keratinocytes) found that KPV blocked reactive oxygen species (ROS) — harmful molecules that switch those command centres on — and lowered the release of an inflammatory signal called IL-1β.^[3] KPV also reduced proteins linked to cell death (Bax, Bcl-2, and cleaved caspase-3).^[3] In short, it appears to interrupt the chain reaction that turns stress into full-blown inflammation.

What the Research Shows

Here is a plain-language tour of the key studies available so far:

• Skin inflammation & pollution damage (2025): Scientists exposed human HaCaT keratinocytes (a standard skin-cell line) to fine dust particles (PM10 — the kind found in urban air pollution). The cells suffered reduced survival and a spike in inflammatory signals. Treating the cells with KPV restored cell viability, cut IL-1β secretion, and tamed ROS-driven inflammation. The protective effect was also confirmed in a 3D skin model, which mimics real tissue more closely than flat cell cultures.^[3]
• Getting KPV through skin (2017): One practical challenge with peptides is making them penetrate the tough outer layer of skin. Researchers tested three delivery methods — microneedles alone (MN), an electrical technique called iontophoresis (ITP), and a combination of both. Passive diffusion (just applying KPV to intact skin with no help) delivered undetectable amounts. Microneedles bumped delivery to 4.4 μg/cm²/h. Combining iontophoresis with microneedles increased permeation by 35-fold compared to microneedles alone, and KPV was detected penetrating more than 100 μm into skin tissue.^[1]
• Analytical stability (2015): A foundational methods paper established a reliable HPLC assay — a chemical test — to measure KPV accurately in both water solutions and skin tissue samples.^[6] This kind of tool is essential for any future research to track how much peptide is actually present and how stable it remains over time.^[6]

What KPV Is Being Studied For

Based on the current published literature, KPV is being investigated in these areas:

• Skin inflammation — protecting keratinocytes from environmental pollutants and oxidative stress^[3]
• Transdermal drug delivery — finding efficient ways to move KPV across the skin barrier for potential topical applications^[1]
• Functional cosmetics and skin-protective treatments — researchers have flagged its potential in formulations designed to defend skin against environmental damage^[3]

It is important to note that all of this work is at the preclinical or early research stage. No large human clinical trials have yet been published for KPV specifically.

How KPV Is Dosed in Research

Because KPV research is still early-stage, there is no universally agreed dosing protocol. The cell-culture study used a concentration of 50 μg/mL applied to human keratinocytes in a lab dish.^[3] Transdermal delivery studies worked with defined permeation rates rather than systemic doses.^[1] For a structured overview of the amounts used across studies, see the dosage chart on this page. You can also use our calculator to explore research concentrations. Remember: these numbers are reference points for scientific study — not recommendations for human use.

Mixing and Storing KPV

KPV is a water-soluble peptide, which makes reconstitution relatively straightforward compared to many other research peptides. In published studies it has been measured in both aqueous (water-based) solutions and skin tissue homogenates, confirming it can be dissolved and kept stable under controlled conditions.^[6] As a general guide for research purposes: reconstitute lyophilised (freeze-dried) KPV powder with sterile bacteriostatic water, swirl gently — do not shake vigorously — and store the resulting solution refrigerated at 2–8 °C. Protect it from light and repeated freeze-thaw cycles, which can degrade small peptides. Always label vials with the date of reconstitution. Unused powder should be kept in a freezer until needed. Proper analytical methods, such as HPLC assays, are recommended to verify concentration and purity before any experimental use.^[6]

Sources

1. Transdermal Iontophoretic Delivery of Lysine-Proline-Valine (KPV) Peptide Across Microporated Human Skin. — Journal of pharmaceutical sciences, 2017. PMID 28343991.
2. Hydrocortisone to Improve Survival without Bronchopulmonary Dysplasia. — The New England journal of medicine, 2022. PMID 35320643.
3. Lysine-Proline-Valine peptide mitigates fine dust-induced keratinocyte apoptosis and inflammation by regulating oxidative stress and modulating the MAPK/NF-κB pathway. — Tissue & cell, 2025. PMID 40073467.
4. International Recommendations for the Diagnosis and Management of Patients With Adrenoleukodystrophy: A Consensus-Based Approach. — Neurology, 2022. PMID 36175155.
5. Trial of Erythropoietin for Hypoxic-Ischemic Encephalopathy in Newborns. — The New England journal of medicine, 2022. PMID 35830641.
6. Stability-indicating HPLC assay for lysine-proline-valine (KPV) in aqueous solutions and skin homogenates. — Biomedical chromatography : BMC, 2015. PMID 25298219.